Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01647321 · ClinicalTrials.gov registry record · NA
Functional Electrical Stimulation for Individuals With Secondary Progressive Multiple Sclerosis
A NA study of Secondary Progressive Multiple Sclerosis, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT01647321: Completed NA study of Secondary Progressive Multiple Sclerosis, sponsored by Johns Hopkins University.
NCT01647321 is a NA study of Secondary Progressive Multiple Sclerosis that has completed, run by Johns Hopkins University. The registered enrollment target is 16 participants, below the 495-participant average among 8 other Secondary Progressive Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01647321, a NA study of Secondary Progressive Multiple Sclerosis, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
Secondary progressive multiple sclerosis (SPMS) is a subtype of multiple sclerosis (MS) for which there are no existing therapies that alter the disease course. This research will utilize cutting edge functional electrical stimulation (FES) cycling technology with the goal of improving walking in individuals with SPMS. The investigators hypothesize that FES cycling will improve walking in subjects with SPMS.
Conditions Studied
Interventions
- BEHAVIORAL Active cycling
- BEHAVIORAL Passive cycling
Study Locations (1)
Maryland
- Johns Hopkins / Kennedy Krieger Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2012-07 |
| Est. Completion | 2019-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01647321
The ClinicalTrials.gov registry entry for NCT01647321 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 495-participant average among 8 other Secondary Progressive Multiple Sclerosis trials with a reported enrollment target (97% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Secondary Progressive Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Active cycling is the first listed.
NCT01647321 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01647321 about?
NCT01647321 is a clinical study titled "Functional Electrical Stimulation for Individuals With Secondary Progressive Multiple Sclerosis". Secondary progressive multiple sclerosis (SPMS) is a subtype of multiple sclerosis (MS) for which there are no existing therapies that alter the disease course. This research will utilize cutting edge functional electrical stimulation (FES) cycling technology with the goal of improving walking in in...
What is the current status of trial NCT01647321?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2012-07. Estimated completion is 2019-10.
What conditions does trial NCT01647321 study?
This clinical trial studies the following conditions: Secondary Progressive Multiple Sclerosis.
What interventions are being tested in trial NCT01647321?
The interventions under investigation include: Active cycling (BEHAVIORAL), Passive cycling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01647321?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01647321 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Secondary Progressive Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Functional Outcomes From Diets in Multiple Sclerosis
RECRUITING · NA
-
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
RECRUITING · Phase 2
-
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
RECRUITING · Phase 3
-
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
RECRUITING · Phase 3
-
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
ACTIVE NOT RECRUITING · Phase 3
-
A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis
COMPLETED
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.